| scholarly article | Q13442814 |
| P2093 | author name string | Marie D Burdick | |
| Robert M Strieter | |||
| Min Huang | |||
| Steven M Dubinett | |||
| Seok-Chul Yang | |||
| Sherven Sharma | |||
| Raj K Batra | |||
| Sven Hillinger | |||
| Jeff F Lin | |||
| Li X Zhu | |||
| P2860 | cites work | Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes | Q24336187 |
| Human Mig chemokine: biochemical and functional characterization | Q24678720 | ||
| Identification and characterization of a novel beta chemokine containing six conserved cysteines | Q28246202 | ||
| Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension | Q28249290 | ||
| Mig and IP-10: CXC chemokines that target lymphocytes | Q28305342 | ||
| Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma | Q28584799 | ||
| Identification of a new mouse beta-chemokine, thymus-derived chemotactic agent 4, with activity on T lymphocytes and mesangial cells | Q28591058 | ||
| Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens | Q34291693 | ||
| Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs | Q34756572 | ||
| Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung | Q35817557 | ||
| The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3 | Q36172008 | ||
| Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities | Q36348799 | ||
| Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells | Q36361823 | ||
| Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases | Q36367319 | ||
| Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms | Q40864365 | ||
| Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo | Q41732041 | ||
| T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. | Q43561148 | ||
| Decreased antigen presentation by dendritic cells in patients with breast cancer. | Q44562482 | ||
| Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome | Q45023842 | ||
| The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis | Q45865382 | ||
| IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. | Q45877131 | ||
| The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor | Q47816803 | ||
| The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. | Q47915773 | ||
| A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells | Q48035864 | ||
| Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells | Q52999151 | ||
| Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells | Q71607047 | ||
| Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis | Q71692071 | ||
| The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model | Q73558121 | ||
| Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12 | Q77303058 | ||
| Chemotactic response toward chemokines and its regulation by transforming growth factor-beta1 of murine bone marrow hematopoietic progenitor cell-derived different subset of dendritic cells | Q77419588 | ||
| Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo | Q77620517 | ||
| Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells | Q77785419 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 22 | |
| P577 | publication date | 2003-04-15 | |
| P1433 | published in | Molecular Cancer | Q15724585 |
| P1476 | title | SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10 | |
| P478 | volume | 2 |
| Q36562161 | A biotherapy based on PSCs-in-3D spheroid-ameliorated biologics depletes in vivo cancer-sustaining stem cells |
| Q34205801 | A cytokine-delivering polymer is effective in reducing tumor burden in a head and neck squamous cell carcinoma murine model |
| Q30428793 | Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3. |
| Q33820300 | CCL21 Cancer Immunotherapy |
| Q28248811 | CCL21 Chemokine Therapy for Lung Cancer. |
| Q40724369 | CXC and CC chemokines as angiogenic modulators in nonhaematological tumors. |
| Q30432791 | CXC chemokines in cancer angiogenesis and metastases |
| Q38040509 | Chemokine-based immunotherapy: delivery systems and combination therapies. |
| Q30426904 | Chemokines as mediators of angiogenesis. |
| Q30438032 | Chemokines as mediators of neovascularization |
| Q30427886 | Chemokines as mediators of tumor angiogenesis and neovascularization |
| Q45879240 | Conference report--gene therapy and lung cancer--no time to wait |
| Q39787154 | Dendritic cell transfected with secondary lymphoid-tissue chemokine and/or interleukin-2 gene-enhanced cytotoxicity of T-lymphocyte in human bladder tumor cell S in vitro |
| Q90381865 | Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review |
| Q39185087 | Evaluation of antibody-chemokine fusion proteins for tumor-targeting applications |
| Q37116507 | Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy. |
| Q33862487 | Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regression |
| Q33803567 | In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection. |
| Q35947942 | Local expression of secondary lymphoid tissue chemokine delivered by adeno-associated virus within the tumor bed stimulates strong anti-liver tumor immunity |
| Q35713347 | Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer |
| Q35842700 | Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia |
| Q21560837 | Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth |
| Q38688006 | Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration |
| Q37705023 | Platelet-derived chemokines: pathophysiology and therapeutic aspects |
| Q75221014 | Priming of naive T cells inside tumors leads to eradication of established tumors |
| Q37900430 | Regulation of angiostatic chemokines driven by IL-12 and IL-27 in human tumors |
| Q37379547 | Review paper: the role of inflammation in mouse pulmonary neoplasia |
| Q30426606 | Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer |
| Q26796395 | Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation |
| Q33584637 | Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice |
| Q89724959 | The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment |
| Q37298417 | The anti-tumor effect and increased tregs infiltration mediated by rAAV-SLC vector |
| Q38023245 | The role of CXC chemokines and their receptors in the progression and treatment of tumors |
| Q26799123 | Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment |
Search more.